Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-05-31 @ 12:10 AM
Study NCT ID:
NCT03164967
Status:
COMPLETED
Last Update Posted:
2023-02-01
First Post:
2017-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Sponsor:
ADMA Biologics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Humoral Immune Response | View |
Keywords: